Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07186777 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of EMTRAS, REMS, and GAP Scores in Trauma

Study acronym: TRAPS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Apr 1, 2026 to Dec 1, 2026
    • Study completion date: Apr 15, 2026 to Dec 15, 2026
    • Site details revised
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this prospective multicenter cohort study is to evaluate and compare the predictive utility of the EMTRAS, REMS, and GAP scores in determining key outcomes among trauma patients admitted to participating hospitals in Iraq. The primary outcomes of interest include mortality, the need for endotracheal intubation, and length of hospitalization. The main questions it aims to answer are: How accurately do EMTRAS, REMS, and GAP scores predict mortality in trauma patients? How effective are these scores in predicting the need for endotracheal intubation? How well do these scores correlate with hospitalization duration in trauma patients? Participants will: Be assessed using EMTRAS, REMS, and GAP scores upon admission to the emergency department. Have their clinical outcomes, including survival, intubation requirements, and length of hospital stay, monitored throughout their hospitalization.
Trial Details
NCT Number NCT07186777
Lead Sponsor Al-Nahrain University
Conditions
(from sponsor)
Trauma Patients
Related terms Wounds and Injuries
Enrollment 188 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov